Become a Member
Dark Mode
Become a Member
Uncovering Hate
WebQoof
Naukri Crisis
Scamguard
Climate Change
Raghav's Take
Members Only
My Report
Brand Studio
More
Business
Tech And Auto
World
Gender
Opinion
Special Projects
Videos
Entertainment
FIT
The Quint Lab
More
Sports
Education
Explainers
Podcasts
Politics
Graphic Novels
Law
Members' Opinion
South Asians
NEON
Dark Mode
Become a Member
Home
Naukri Crisis
Scamguard
Uncovering Hate
Special Projects
About Us
T&C
Privacy Policy
BECOME A MEMBER
Created by potrace 1.16, written by Peter Selinger 2001-2019
FOLLOW US ON
About Us
Contact Us
Privacy Policy
ADVERTISEMENT
REMOVE AD
×
×
DGCI
DCGI Grants Emergency Use Approval to Corbevax Vaccine for 12–18 Age Group
DGCI Grants Conditional Market Approval for Covaxin & Covishield
ADVERTISEMENT
REMOVE AD
DCGI Grants Emergency Use Approval to Corbevax Vaccine for 12–18 Age Group
DGCI Grants Conditional Market Approval for Covaxin & Covishield
DGCI Gives Nod For Phase-3 Trials of Bharat Biotech’s Intranasal COVID Vaccine
Covaxin Approved for Children Between 2-18 Yrs By Expert Panel: How Safe is It?
